Immune Regulation by Deubiquitination
Immune Regulation by Deubiquitination
批准号:
9788250
负责人:
Michael Croft
金额:
$45.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-19 至 2023-08-31
关键词:
AblationActin-Binding ProteinAddressAdoptive TransferAffectAntibody FormationAntigensAutoantigensAutoimmune DiseasesB-Cell DevelopmentB-LymphocytesBiologicalBiological AssayBiological ProcessCD4 Positive T LymphocytesCell CommunicationCell CountCell physiologyCellsChronicCommunicable DiseasesDeubiquitinating EnzymeDeubiquitinationDevelopmentDiseaseEnzymesExcisionExhibitsFOXP3 geneGene ExpressionGoalsHelper-Inducer T-LymphocyteHumanIL4 geneImmune System DiseasesImmune ToleranceImmune responseImmune systemImmunizationIn VitroInflammationInflammatoryInterleukin-4InvadedJournalsKnowledgeLungLung InflammationLymphoid TissueMediatingModelingMolecularMusPathway interactionsPeer ReviewPhenotypePlayProcessProductionProtein DeficiencyProteinsPruritusPublishingRegulationRegulatory T-LymphocyteRoleSignal TransductionSolidStructure of germinal center of lymph nodeSystemT cell regulationT-LymphocyteT-Lymphocyte SubsetsTestingTherapeutic InterventionTimeTissuesUbiquitinUbiquitinationVaccinationVirus Diseasesantigen challengeautoinflammatorybasecytokinedesignexperimental studyhuman diseaseimmunoregulationin vivomigrationnamed groupnovelnovel therapeutic interventionpathogenprotein biomarkersresponsesuccesstranscription factorubiquitin-protein ligase
中文摘要
项目摘要
我们的长期目标是研究免疫调节中的泛素系统。我们发起了一个
一项新的去泛素化酶CYLD的研究发现,T细胞CYLD的缺乏,
调节细胞(Treg)通过增加IL-4的产生而引起慢性肺部炎症。
这些初步的研究指出了CYLD调节TGFAP的新机制,
调节细胞因子的产生,并强调了潜在的组织特异性方面,
Treg功能。最近,我们发现CYLD作为一个积极的调节剂,在
在淋巴组织中Treg向T滤泡调节性T细胞(Tfr)的分化。这些
因此,初步研究为我们检验中心假设提供了坚实的基础
泛素化/去泛素化系统在免疫调节中起着关键作用
通过以组织环境依赖性方式调节不同的T细胞亚群。这里我们
我计划通过提出两个具体目标来检验这一假设:目标1,研究CYLD,
目的2:研究CYLD在Tfr中的作用。预期结果将
显著推进我们对蛋白质去泛素化途径的基础知识,
免疫调节,并将为人类疾病的治疗干预提供线索。
英文摘要
Project Summary
Our long-term goal is to study the ubiquitin system in immune regulation. We initiated a
new study of the deubiquitinating enzyme CYLD and found that deficiency of CYLD in T
regulatory cells (Treg) caused chronic lung inflammation by increasing IL-4 production.
These preliminary studies pointed to new mechanisms of CYLD regulation of Tregs, via
modulating the cytokine production, and highlighted potential tissue-specific aspects of
Treg function. Recently, we found that CYLD acts as a positive regulator in the
differentiation of Treg to T follicular regulatory T cells (Tfr) in lymphoid tissues. These
preliminary studies thus provide us with a solid basis for testing our central hypothesis
that the ubiquitination/deubiquitination system plays a critical role in immune regulation
via modulating different T cell subsets in tissue context-dependent manner. Here we
plan to test this hypothesis by proposing two Specific Aims: Aim 1, to study CYLD in
Treg regulation; and Aim 2, to study the role of CYLD in Tfr. The expected results will
significantly advance our basic knowledge on the protein deubiquitination pathway in
immune regulation, and will provide clues to therapeutic intervention of human diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TWEAK and Skin Inflammation
-
批准号:10400699
-
项目类别:
-
资助金额:$39.2万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
-
批准号:10531229
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
Immune Regulation by Deubiquitination
-
批准号:9982199
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
-
批准号:10053328
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
TWEAK and Skin Inflammation
-
批准号:9910059
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
-
批准号:10310411
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
TWEAK and Skin Inflammation
-
批准号:10152528
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2018
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:9321444
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:10675443
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:10269804
-
项目类别:
-
资助金额:$37.53万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Training in Immunological Mechanisms
-
批准号:10458735
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Novel PTPRD interaction Controlling T cell Responsiveness
-
批准号:9077779
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2016
-
负责人:Michael Croft
-
依托单位:
Structural Characterization of 4-1BB-Galectin-9 Complexes
-
批准号:8679808
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2014
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:8577804
-
项目类别:
-
资助金额:$41.6万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:8661698
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Novel costimulatory pathways required for T cell regulation
-
批准号:8495230
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:9267076
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:9054041
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Control of Airway Tolerance
-
批准号:8839196
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Michael Croft
-
依托单位:
Novel costimulatory pathways required for T cell regulation
-
批准号:8377924
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2012
-
负责人:Michael Croft
-
依托单位:
海外基金